Androgen excess
ICD-10 E28.1 is a billable code used to indicate a diagnosis of androgen excess.
Androgen excess refers to an abnormal increase in androgen hormones, which are primarily produced by the adrenal glands and gonads. This condition can manifest in various ways, including hirsutism, acne, menstrual irregularities, and infertility in women. The underlying causes of androgen excess can be multifactorial, often involving disorders of the adrenal glands, such as adrenal hyperplasia or adrenal tumors, as well as ovarian dysfunction, such as polycystic ovary syndrome (PCOS). Additionally, pituitary disorders can contribute to hormone imbalances that lead to increased androgen levels. Diagnosis typically involves a combination of clinical evaluation, hormonal assays, and imaging studies to identify the source of excess androgens. Treatment may include lifestyle modifications, hormonal therapies, and surgical interventions, depending on the underlying cause. Accurate coding for androgen excess is crucial for appropriate management and reimbursement, as it often intersects with various endocrine disorders and requires a comprehensive understanding of hormonal pathways.
Detailed hormonal assay results, imaging studies, and clinical symptoms.
Patients presenting with hirsutism, menstrual irregularities, or infertility.
Ensure comprehensive documentation of all hormonal levels and potential differential diagnoses.
Menstrual history, physical examination findings, and any relevant imaging.
Women with irregular periods and signs of hyperandrogenism.
Document any treatments initiated and their outcomes to support coding.
Used to evaluate androgen levels in patients suspected of having androgen excess.
Document the reason for testing and any relevant clinical findings.
Endocrinologists should ensure comprehensive hormonal panels are ordered.
Common symptoms include hirsutism, acne, irregular menstrual cycles, and infertility. Patients may also experience weight gain and mood changes.
